Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomasRaphael Koch, David M. Weinstock, Jennifer L. Crombie et al.|Blood|2018Cited by 63
ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomasBaishan Jiang, Wenchao Wu|Cell chemical biology|2023Cited by 15